Senseonics Holdings Inc (NYSEAMERICAN:SENS) saw a significant growth in short interest in February. As of February 15th, there was short interest totalling 5,615,001 shares, a growth of 21.1% from the January 31st total of 4,635,391 shares. Currently, 11.6% of the company’s stock are sold short. Based on an average daily trading volume, of 416,946 shares, the short-interest ratio is presently 13.5 days.
In related news, major shareholder Peter J. Barris sold 139,645 shares of the business’s stock in a transaction that occurred on Friday, December 8th. The shares were sold at an average price of $2.63, for a total value of $367,266.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 34.10% of the company’s stock.
Large investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. bought a new position in Senseonics in the fourth quarter worth approximately $108,000. Bank of New York Mellon Corp acquired a new position in shares of Senseonics during the third quarter worth $116,000. Perceptive Advisors LLC acquired a new position in shares of Senseonics during the third quarter worth $160,000. Citadel Advisors LLC acquired a new position in shares of Senseonics during the third quarter worth $194,000. Finally, BlueCrest Capital Management Ltd acquired a new position in shares of Senseonics during the fourth quarter worth $198,000. 30.66% of the stock is owned by institutional investors.
Separately, Canaccord Genuity reissued a “buy” rating on shares of Senseonics in a research note on Wednesday, November 1st.
Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.